R&D at the cutting edge As a research-driven enterprise, Chiesi Group invests almost 15% of turnover in research and development in our main therapy areas: respiratory, neonatal, inflammatory and rare diseases. This passionate commitment to innovation in terms of both active ingredients and new formulations is yielding record results, with patents being filed at a rate of one or more every working day (in 2008) and an exceptionally promising pipeline of potential new medicines. A world class new research hub An exciting addition to our research facilities in Italy, France, the UK and the USA is a large new state-of-the-art research in Chiesi’s birthplace of Parma. Equipped with all the skills and technologies needed for identifying lead compounds, preclinical and clinical development and managing regulatory activities and our worldwide R&D portfolio, this sustainable, energy-efficient new facility will coordinate operations at our other international research sites in Chippenham (new drug delivery platforms), Paris (clinical research) and Rockville in Maryland (clinical and regulatory activities). Home About Chiesi Research & Development Product Portfolio Patient Focus Working in Partnership Join Chiesi Contact Us Contact Us | Privacy Policy | Terms of Use | Cookie Policy Copyright © 2013 Chiesi Ltd All rights reserved. Registered in England and Wales No. 02140985. VAT Registration No. 686750782